Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04053868 · ClinicalTrials.gov registry record · NA

Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes

A NA study of Tobacco Smoking and Vaping, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
17
Enrollment target
2
Study locations

NCT04053868 is a NA study of Tobacco Smoking and Vaping that has completed, run by University of California, San Francisco. The registered enrollment target is 17 participants, below the 477-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04053868, a NA study of Tobacco Smoking and Vaping, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
2
Study locations

Study Summary

This is an observational, crossover design that will examine the pharmacokinetics and pharmacodynamics of impact of smoking tobacco cigarettes or vaping the JUUL electronic cigarette.

Interventions

  • OTHER JUUL
  • OTHER Tobacco

Study Locations (2)

California

  • Zuckerberg San Francisco General Hospital - San Francisco
  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2019-12-09
Est. Completion 2022-03-31
Phase NA

What the Registry Record Tells You About NCT04053868

The ClinicalTrials.gov registry entry for NCT04053868 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 477-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (96% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Tobacco Smoking appearing as the primary indexed condition, and to 2 interventions - of which JUUL is the first listed.

NCT04053868 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04053868 about?

NCT04053868 is a clinical study titled "Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes". This is an observational, crossover design that will examine the pharmacokinetics and pharmacodynamics of impact of smoking tobacco cigarettes or vaping the JUUL electronic cigarette.

What is the current status of trial NCT04053868?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2019-12-09. Estimated completion is 2022-03-31.

What conditions does trial NCT04053868 study?

This clinical trial studies the following conditions: Tobacco Smoking, Vaping, Nicotine Administration & Dosage, E-cigarettes, E-Liquid.

What interventions are being tested in trial NCT04053868?

The interventions under investigation include: JUUL (OTHER), Tobacco (OTHER).

Who is sponsoring clinical trial NCT04053868?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04053868 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.